aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in 1884 as the New York Cancer Hospital, Memorial Sloan Kettering Cancer Center (MSK) is a specialized, non-profit oncology hospital located in Manhattan, New York City. MSK's core mission is to lead in cancer treatment, research, and education, aiming to transform care and improve patient outcomes. The center offers a range of services including urgent care, and it has developed health-focused mobile apps and educational programs to support patients and healthcare providers.
Notable affiliated individuals include pioneering oncologists and researchers who have significantly advanced cancer treatment. MSK has received substantial funding from philanthropic sources and research grants, contributing to its cutting-edge facilities and innovative research programs. Key achievements include numerous breakthroughs in cancer therapies and a robust portfolio of clinical trials. MSK's impact is profound, as it continues to set benchmarks in oncology care and research globally.
Operating Status
Active
Ownership Type(s)
Non-profit
Main Product(s)
Research, Cancer Treatment
Technology
Telemedicine
Tags
Healthtech
Revenue Type(s)
Consulting
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
United States
When was Memorial Sloan Kettering Cancer Center founded?
Memorial Sloan Kettering Cancer Center was founded in 1884.
Where is Memorial Sloan Kettering Cancer Center's headquarters located?
Memorial Sloan Kettering Cancer Center's headquarters is located in Greenwich, CT, US.
When was Memorial Sloan Kettering Cancer Center's last funding round?
Memorial Sloan Kettering Cancer Center's most recent funding round was for $5k (USD) in July 2023.
How many employees does Memorial Sloan Kettering Cancer Center have?
Memorial Sloan Kettering Cancer Center has 19541 employees as of Feb 5, 2024.
How much has Memorial Sloan Kettering Cancer Center raised to-date?
As of July 05, 2023, Memorial Sloan Kettering Cancer Center has raised a total of $102.2M (USD) since Jul 12, 2023.
Add Comparison
Total Raised to Date
$102.2M
USD
Last Update Jul 12, 2023
Last Deal Details
$5k
USD
Jul 12, 2023
Grant
Total Employees Over Time
19.5k
As of Feb 2024
Memorial Sloan Kettering Cancer Center Address
Greenwich,
Connecticut
06830
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts